Description
Fragment 176-191 5mg is a modified peptide segment derived from human growth hormone, specifically designed to target adipose tissue metabolism. This research compound demonstrates potential lipolytic properties without affecting insulin sensitivity or glucose regulation. Each vial contains a precisely measured...
Fragment 176-191 5mg is a modified peptide segment derived from human growth hormone, specifically designed to target adipose tissue metabolism. This research compound demonstrates potential lipolytic properties without affecting insulin sensitivity or glucose regulation. Each vial contains a precisely measured 5mg dose, formulated to exacting pharmaceutical standards for laboratory research applications.
